Delivery Order SPE2DB24D1205-SPE2DB25FCZJW
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,942.82 to AmerisourceBergen Drug Corp for Alfuzosin HCL ER 10 mg tablets (90-count supply) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $1,459.36 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Alfuzosin HCL ER 10 mg tablets (90-count packages). This firm fixed-price delivery order, with a completion date of September 16, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Alfuzosin HCL ER 10 mg tablets (120 count) with a ceiling value of $1,234.86 under a firm fixed price contract type. The award, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, was competitively awarded with no set-aside designation. Performance of this delivery order will be executed from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Alfuzosin HCL ER 10 mg tablets (90-count) with a ceiling value of $10,418.52. The contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and utilizes firm fixed pricing with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Alfuzosin HCL ER 10 mg tablets (120-count units) with a contract ceiling value of $3,174.90 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Alfuzosin HCL ER 10 mg tablets (120-count) with a ceiling value of $4,953.94. This is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- This contract award for $1,415.85 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Alfuzosin HCL ER 10 mg tablets and has an ultimate completion date of October 13, 2023. The contract is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Alfuzosin HCL ER 10 mg tablets (90-count units) on September 9, 2025, with a ceiling value of $18,135.41. This firm fixed price delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Alfuzosin HCL ER 10 mg tablets (120-count units) valued at $1,240.25. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The order is scheduled for completion by July 29, 2025, with performance to be executed from AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order valued at $1,367.28 to AmerisourceBergen Drug Corp for Alfuzosin HCL ER 10 mg tablets (90-count supply) on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZJWDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,186.91 to AmerisourceBergen Drug Corp for the supply of Alfuzosin HCL ER 10 mg tablets (90-count) under a firm fixed price arrangement. The contract, which was competitively awarded with no set-aside designation, is scheduled for completion by August 11, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction within the company's broader federal pharmaceutical supply portfolio serving military and veteran healthcare systems. This award is issued as a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medications, vaccines, syringes, vials, and medical test kits across multiple therapeutic domains. AmerisourceBergen's consistent performance on competitively awarded federal contracts demonstrates its capability to meet the DLA's medical supply chain requirements, with delivery orders ranging from minimal transactions to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 8/8/25 |